SCHEMBL527326

SCHEMBL527326

Cc1ccncc1-c1c(C)cccc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 9/20 0.43
CYP3A4 P08684 4/20 0.43
CYP2D6 P10635 3/20 0.43
CYP2C9 P11712 3/20 0.43
CYP2C19 P33261 3/20 0.43
LMNA P02545 1/20 0.43
LCK P06239 1/20 0.43
BTK Q06187 1/20 0.43
CD44 P16070 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
ABL1 P00519 1/20 0.42
CYP17A1 P05093 9/20 0.41
CYP2E1 P05181 2/20 0.41
CYP2C8 P10632 2/20 0.41
CYP2A6 P11509 2/20 0.41
CYP2B6 P20813 2/20 0.41
PDE10A Q9Y233 1/20 0.40
DPP4 P27487 1/20 0.40
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2940700 0.86 LCK (0.42) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL27897076 0.80 LCK (0.51) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL527396 0.80 LCK (0.48) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9678804 0.76 CYP3A4 (0.54) CYP3A4CD44DPP4TDP1
SCHEMBL29988790 0.75 TDO2 (0.49) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL3421743 0.75 TDO2 (0.49) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL30309922 0.75 LCK (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL15784053 0.75 LCK (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6172101 0.74 CYP2A6 (0.53) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL12811651 0.74 CYP1A2 (0.51) CYP1A2CYP3A4CYP2D6CYP2C19CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598481-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS Bristol-Myers Squibb Company (US) 2013-06-05 EP disclosed
WO-2012015723-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-02 WO disclosed